NCT02061813 - Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

January 31, 2014

Study Completion Date

May 31, 2014

Conditions

Head Lice

Interventions

DRUG

Abametapir Lotion 0.74% w/w

applied 0.2 mL topically under occlusive condition

DRUG

Sodium Lauryl Sulfate

Sodium Lauryl Sulfate is prepared as a 0.2% aqueous solution by the site for topical administration, and applied 21 times over consecutive days under occlusive conditions, will serve as a positive control.

DRUG

Saline 0.9%

A solution of 0.9% saline for topical administration, applied 21 times over consecutive days under occlusive conditions, will serve as a negative control

DRUG

Placebo

Trial Locations (1)

07652

TKL Reserach Inc, Paramus